Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9585 | 1074 | 46.5 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TRIM5 ALPHA | Author keyword | 128 | 90% | 5% | 55 |
2 | TRIMCYP | Author keyword | 41 | 100% | 1% | 15 |
3 | TRIM5 | Author keyword | 35 | 86% | 2% | 18 |
4 | TRIM22 | Author keyword | 34 | 93% | 1% | 13 |
5 | MULIBREY NANISM | Author keyword | 22 | 81% | 1% | 13 |
6 | TRIPARTITE MOTIF | Author keyword | 22 | 81% | 1% | 13 |
7 | RESTRICTION FACTOR | Author keyword | 16 | 41% | 3% | 31 |
8 | TRIM37 | Author keyword | 15 | 88% | 1% | 7 |
9 | B302 DOMAIN | Author keyword | 13 | 80% | 1% | 8 |
10 | MID1 | Author keyword | 12 | 52% | 2% | 17 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRIM5 ALPHA | 128 | 90% | 5% | 55 | Search TRIM5+ALPHA | Search TRIM5+ALPHA |
2 | TRIMCYP | 41 | 100% | 1% | 15 | Search TRIMCYP | Search TRIMCYP |
3 | TRIM5 | 35 | 86% | 2% | 18 | Search TRIM5 | Search TRIM5 |
4 | TRIM22 | 34 | 93% | 1% | 13 | Search TRIM22 | Search TRIM22 |
5 | MULIBREY NANISM | 22 | 81% | 1% | 13 | Search MULIBREY+NANISM | Search MULIBREY+NANISM |
6 | TRIPARTITE MOTIF | 22 | 81% | 1% | 13 | Search TRIPARTITE+MOTIF | Search TRIPARTITE+MOTIF |
7 | RESTRICTION FACTOR | 16 | 41% | 3% | 31 | Search RESTRICTION+FACTOR | Search RESTRICTION+FACTOR |
8 | TRIM37 | 15 | 88% | 1% | 7 | Search TRIM37 | Search TRIM37 |
9 | B302 DOMAIN | 13 | 80% | 1% | 8 | Search B302+DOMAIN | Search B302+DOMAIN |
10 | MID1 | 12 | 52% | 2% | 17 | Search MID1 | Search MID1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | B302SPRY DOMAIN | 237 | 97% | 6% | 67 |
2 | MONKEY TRIM5 ALPHA | 224 | 95% | 7% | 75 |
3 | RETROVIRAL RESTRICTION | 181 | 80% | 10% | 111 |
4 | RETROVIRUS RESTRICTION | 166 | 84% | 8% | 90 |
5 | RESTRICTION FACTOR TRIM5 ALPHA | 118 | 95% | 4% | 39 |
6 | POSTENTRY RESTRICTION | 116 | 92% | 4% | 46 |
7 | RHESUS TRIM5 ALPHA | 80 | 90% | 3% | 35 |
8 | TRIM5 ALPHA | 60 | 63% | 6% | 61 |
9 | TRIM5 ALPHA RESTRICTION | 48 | 77% | 3% | 33 |
10 | SPECIES SPECIFIC TROPISM | 47 | 88% | 2% | 22 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
TRIMmunity: The Roles of the TRIM E3-Ubiquitin Ligase Family in Innate Antiviral Immunity | 2014 | 14 | 158 | 55% |
HIV-1 capsid: the multifaceted key player in HIV-1 infection | 2015 | 1 | 130 | 53% |
The control of viral infection by tripartite motif proteins and cyclophilin A | 2007 | 137 | 85 | 71% |
TRIM family: Pleiotropy and diversification through homomultimer and heteromultimer formation | 2012 | 28 | 62 | 65% |
Tripartite-motif proteins and innate immune regulation | 2011 | 79 | 79 | 53% |
HIV-1 uncoating: connection to nuclear entry and regulation by host proteins | 2014 | 8 | 116 | 53% |
Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection | 2007 | 89 | 93 | 73% |
Gene Therapy Strategies to Exploit TRIM Derived Restriction Factors against HIV-1 | 2014 | 6 | 136 | 58% |
Capsid-binding retrovirus restriction factors: discovery, restriction specificity and implications for the development of novel therapeutics | 2013 | 11 | 121 | 79% |
Anti-retroviral activity of TRIM5 alpha | 2010 | 35 | 128 | 70% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AIDS CANC IMMUNOL AIDS | 6 | 100% | 0.4% | 4 |
2 | PROT NUCLE ACID CHEM | 5 | 23% | 2.0% | 21 |
3 | VIRAL INFECT | 5 | 15% | 2.8% | 30 |
4 | CANC IMMUNOL AIDS AIDS | 4 | 50% | 0.6% | 6 |
5 | PATHOL AIDS CANC IMMUNOL AIDS | 4 | 75% | 0.3% | 3 |
6 | DANA FARBER CANC AIDS | 3 | 60% | 0.3% | 3 |
7 | VIRAL GENOM | 2 | 28% | 0.7% | 7 |
8 | MALAD INFECTUMR 8104 | 2 | 67% | 0.2% | 2 |
9 | HARVARD PROGRAM VIROL | 2 | 50% | 0.3% | 3 |
10 | MED N A5301 | 2 | 50% | 0.3% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000166708 | APOBEC3G//VIF//APOBEC3F |
2 | 0.0000132553 | VIRUS CELL INTERACT SECT//GAG//M PMV |
3 | 0.0000127081 | VPU//BST 2//TETHERIN |
4 | 0.0000098894 | DAXX//PML//PML NUCLEAR BODIES |
5 | 0.0000092631 | VPR//VPX//HIV 1 VPR |
6 | 0.0000072999 | KRAB DOMAIN//KRAB//SCAN DOMAIN |
7 | 0.0000069228 | U BOX//CELLULAR BIOL MOL GENET//PLANT BIOL GRP PROGRAM |
8 | 0.0000059001 | HIV 1 INTEGRASE//INTEGRASE//RALTEGRAVIR |
9 | 0.0000055596 | SIV//SHIV//SIMIAN IMMUNODEFICIENCY VIRUS |
10 | 0.0000048901 | LENTIVIRAL VECTOR//LENTIVIRAL VECTORS//EXPT HEMATOL |